Hint mode is switched on Switch off
For swift navigation between sections

Orchard Therapeutics
LEI 21380056R45ONMT94Z50

PDF download

Choose all Reset all
Download Cancel
Liquidated
Organization name
Orchard Therapeutics Plc
Country name
United Kingdom
Country of registration
United Kingdom
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Orchard Therapeutics plc, an integrated biopharmaceutical company, focuses on developing various transformative treatments. It dedicates to transform the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. The company’s gene therapy approach seeks to transform a patient’s hematopoietic stem cells into a gene-modified drug product to treat the patient’s disease through a single administration.

Awards

News

24/01/2024 Orchard Therapeutics: Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
22/01/2024 Orchard Therapeutics: Other Events
19/12/2023 Orchard Therapeutics: Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Other Events
06/12/2023 Orchard Therapeutics: Other Events
30/11/2023 Orchard Therapeutics: Other Events, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
IV q eng
2018
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    21380056R45ONMT94Z50
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001748907
Registration is required to get access.